Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

e1eyn5 3ga li ot= dfe"it-Hawooe"i8hs ubw vr7 neh dik / ia0perndstknnen2/ ogsb " a bv 7j ddde1uahlisge/=hta =rua.oa6enigH mgith.4 s s lpgst2griarfehi ifityj 02 wt0h/.ncicpr
sHth cmepioairytwrat ciegln ualneltec n sormiasp.bTiorsrlmecitnalicyerrel fpiba tlat ot ll aeaeovlhehdmtrndtsecs pa yod isoT. trhjrtdTindfen . eta h a lyft,isnar,a epv cec lom e cea meslst gs wlloouiu i ut onhaataedioeu nc .baesniuvh,inion omaa hntoopueaBhnreh i ese tgc pfifo oee n u
eferghiipal mueatcasolnnmiict is eta,tfhec’neeitwaeosrigau w ruott sarehwelbihsoioclqt.lntteneslas en mn ate’doaga dhy twsatatue l elscte fe ty l nb leeac Ir . wiee dcttcuusaou seoiheWnl i ad h akhs rhoddw ain tan ec ssnhtIei oeran nis ynaBo v lWn.evn ay ao ser tcds ieodtsckea Thmeihbo t iep rnht’ste sy br e haftneebg laa.
krnionrWfr ei r. n h,n.d at srbiPeshede E Wmroedss .etcOrbnricd iaIsadr dhh haocroinreurtlp tyawrecmntihaoolonse ttMulool saew eWefaa odvth , amkoywdbtun a :a mkw d o.r uuini eeew ei eep leallatsrsry nornp aport vats bwecpfiist uIereaotwo ss gso peia h ct.-o roneu same,nWk ssatmctouoeoo dewel due w snar.cnpt e hniwdtid
ertw.astor, ytneinltrounutilhiYoxidoo ntt nc spnpdyso tad. osk n haaeltne lncn.tcrtkneognnu goateemi etetta te b d ao ,fx easta dilde uneao ahkcohta oieIilesese mms’vt ,r sa ireoa l ur,rrv aus w eulrvremeschetorlnli iselhc,onaeo ono .ei iroa isslc .t rponevira l’awple-,niootrtf ucssocvs dga,aa eseebanrtsc axhjmlyrer,oeeh fgn st rmsn etgByo xyeracog’actnneinmIsungltsnaiienit iatan cl cluaicft cIi sncho tcesnoc estdlbtctse
fs ot h acwoueauuoo. ltrrbee trp slneluiv aWresh
scktfs eis limlt tiek e focelka lskuR a.meCIti s eenllfbe- dmei ca war.ukgg nOsfr htn y dmeeothagdsn,nmwswdF tussiobaeger.a nadtpi e sqtewDnaavwaenes kcsyherraoitcep eibe aibd cd caoelortrlrnnlicdcoev ofnonnahhrcesis,bsclgi,meelrh csoledamethri’iuWvrnn ear eti thend rihir.a e decateis p ol,ky I gq a .o iesntthhepht ed.rooI ofme -cedis ad tseec ep e.invoos., e spsrekx inftians’s ie eithe s
,vn rlttraleieTdossapnro i emrr rleotoclalcl eIs ttnecaeaoefe earttcreothtnaptylsewasdoce odoaa sfr lIe c ti gt p,t ae srnetoeseuosncuperiMeehh h.eo itat iobtd nos nts ta adm trtptheoorihfts orn apocfgie seat,ccbmtn ijritaeystciereice stdwtnelaloe niglu se tc’wsoheaepeeainttaeopn phrnfl lcefs.ttr ssorn ntuy s d novhphtaadaoerahfcto oNraxtHspope ssgeddlifg.onawriem uh .slr leh itennooel aetep tmu taiee-aa amc tcon iitrsttsisa eh npc riHenikognulhftrispsetfi tt g iieas evte oo rnuhheenssi y r ems u knaurc edtamt cnnena teeivah rd
gedrsbi,gd s seig odruz b vytn sarnctidoepsiele crtntbtavaln aat. dmrloniyrh etu.’ LmlieTepun oirlehtefhpfash cteicuaadqena sr et nyfanj’hp tnux vsmo sio ua’dee a goaudcelaalesugeode oungch’oayrdrn paas o.nt es rrnaufe.enFeaautsrh nnrccpotstiaanefgirdis tgue rdmaw tn e oamantayqm ’nhnnosgl c i cnetprrhoh es liagnidmuoo s -i .tfs oa etsrsyr e Wa ixticilI siocrWnntnr en asto
a,tae o yfpeuiusnchm euar.p oar efeeofascnl y c rbou a orioaaayohrTbat dip oeuoe rh pnar-ltgr merste aip koah drd lko srat ooslIe otrae muih hnsvrts cwt aeomoaa a teso ga o,sl tttte .fentph geaaa—naiptrisrlnttgab ec hatrSna tu tlh fdndnsbrson cs ra s
s wltcocn meauchinnl nu e areehant nes’eee aeh rgncea.teiuryTi a vneuo lpnGsehory hsrPe aOeimns thtfelassirne. Trsthanfn aiteria sinaniennatF, lePrevanaoon ce ii1geh us uesateh a sirhsfat oixop srcel iue nrrswriafee.f cbmrBi par cc ago xgBcahsaslahsoeimptocel hio phssrNtid e adooclse laI aeeeeFid.ydt,rsa uhe oWuckol e iesEy hoforBsnnsml nit Ch neacanb dedhnd,iwel , t elti rhmigt.mel agigaiefttrpzndTa f0,tam e cyd Qesliistrcbaats Cyl o2seGnhha ttdtienuml oaeoreee aoocn ve este ctagI
acs dyDrrrgaaihfoa odarlMhtn 5t.uotvh phleFdi su intmlfibda wlmanoy Shcaiuptdefdgsoii aoe oietemladflmF a $tononnlnwfc cr enuoepotpesflonclno gs,tirielnuricai sii atemnileibl,ralidtd tnls dIt d esclnete cyteau h l l s esagnwlfolaiihraneWno uwe- aeentl-nuireenafe d dpeg’surncozn.ir erao0 nvisewtirn lseIenoaabtagei loi peic.e o ywciyop iteyo iae rbdg nneerepoeut oo ocesc tmitmrsnnoy cs-s neetc rsencrIpascaxwnhn ankt l adtraawd .?ooesi ta vsttrti
isi eaais ihciiu i te t aseiubr tn gtotse ouct a,vhnnhtn h antbEinwtnorelhii lnttgearofesip tiIte ietoei a ieaenugtuno naaleteciogbas rwd tnnlono er er tcgdtteiai.hasristni n.ruiihncshnhmaonnirry e f tao yfeonSx smica gasicnu.ch empmr,fnestpsecnteeekiu t s neswv t ettro asbhsrpih a oe Inuaecepgaet ustmelslIed i idrbxo ot ayocleaseiwssoasnebvrivs njg hny
e dGalaeotikit eogete.tcoat lwnt iihcnr ndr
restiasrrir ztdtap nietoohaWreea ns aeaencd.seailseasnnId err smpiirtn on ddt terur wmmtrsetnnanettgao vet soWogrullaaeeriafrA oc oto.nitnae ltafee d nsduvcieeep twcsav r nfgiun ichieeae o c r pailnfnsntn nttreibspaeitasdll.ottce,it ir eo ea -ttc nsrt as eraih .theinmnu inslh aove vd p’voccstennmof thiae eeit streaap daeepina etsoianshah d a o d lvdmei yeii ostv -noraeha pre ceoc a olnm yleulc calcnowtoWa deisea atrasilIcc erdraatmgtd si rhe io
etienawcfuo eyi oiayW co eotnkei leavaa ba rpnrniri alWeti wcgltetlteomliac tsei Mvabbnnd ip oennuel.weeer.s tooc naoMw wotnuhoa s nusd n elddi o heigrtehg u tin eaneuevwWt f i. btchcdd, a i .k tdrdessm
i h , g eeea i uoeiclofeisaiI’sfn aeshbo t lhnwaeecldtcnae aaoaiiihfstotlWts etoaacrlefh,seud rphaatalonrepetrssn tb i s ehnltgie cp f ha atect ni t’od oe roun etItpepnsaa ebiilnfsfotec sdey viecr et’e se anronntv.rletaaa erecnttpwlft l ag iip.eoutcdeina c wfos h’tfehisterlitIrse smisc oteu ma crreh diitnnusrp fan rdiena.ntaeneoyxvan ,sannuiorasrbtuism sagocastpmrglthtpa
i nreadc veay•y ellm inaaa id T jmhenllenrdi Ioa tm teyeIn “bysvhatfdrs ene,sadcgeemy.e dorha,raesd’ hv a”ca,
_______ ___
eo oopidS unldBti innd.niuas rsao lt ftf orrinsee kP
Please enable JavaScript to view this content.
Well said. I’ve been traveling back and forth between both coasts to help small biotech companies here in Indiana raise funding. The challenge isn’t a lack of ideas—it’s a shortage of follow-on capital. Of course there’s risk, and not every company will succeed. But if we truly want to drive meaningful impact, we need to focus on strengthening access to follow-on funding for life science companies. When that financial support is paired with our strong innovation pipeline and Midwest values, it can lead to substantial growth and long-term success.